Stiefel, a GSK Company
Closed portfolio with a later-stage archive tilt
According to ClinicalTrials.gov-derived indexes, Stiefel, a GSK Company sits in the top decile of US sponsors by registered trial count (#456 of 15,742 sponsors by registered trial count).
Stiefel, a GSK Company: 37 sponsored US clinical trials, none currently recruiting.
Stiefel, a GSK Company sponsors 37 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 37 completed. 22 of these trials are in Phase 3-4 (later-stage) and 14 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Acne Vulgaris, with 6 trials.
Top-decile sponsor footprint
Stiefel, a GSK Company ranks in the top decile of sponsors by registered trial count (#456 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
37 of 37 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (100.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Indexed trials (enrollment closed)
37 total, page 1 of 1
A Study to Evaluate Clinical Effect, Pharmacokinetics , Safety, and Tolerability of Umeclidinium in Palmar Hyperhidrosis Subjects
NCT02673619
A Single Dose Phase I Exploratory Study in Healthy Volunteers With GSK2894512 Cream
NCT02411162
A Study to Evaluate the Irritation Potential of GSK2894512 Cream on Skin in Healthy Subjects
NCT01984775
U0289-405: An Open-Label, 12-Week Study to Evaluate the Efficacy and Safety of the Acne System (Benzoyl Peroxide 2.5%, Salicylic Acid 0.5%) in Subjects With Acne
NCT01446237
Ethanol-Free Clobetasol Propionate Foam 0.05% (Olux-E Foam) vs Vehicle Foam in the Treatment of Chronic Hand Dermatitis.
NCT01323673
A Study to Evaluate the Potential of Tazarotene Foam to Cause an Allergic Reaction When Applied to the Skin and Exposed to Light on Healthy Volunteers.
NCT01119651
The Purpose of This Study is to Demonstrate the Safety and Effectiveness of Calcipotriene Foam in Subjects With Scalp and Body Psoriasis
NCT01139580
A Study to Evaluate the Potential of Tazarotene Foam to Cause a Reaction When Applied to the Skin and Exposed to Light on Healthy Volunteers
NCT01115322
A Study To Evaluate The Contact Sensitization Potential Of Tazarotene Foam On Skin In Healthy Volunteers
NCT01114841
A Study to Evaluate the Irritation Potential of Tazarotene Foam on Skin in Healthy Volunteers
NCT01112787
A Study to Compare the Blood Levels of Albaconazole in Healthy Subjects Who Have Received a Single Dose of 400 mg Albaconazole as a Tablet Versus Albaconazole as a Capsule
NCT01039883
A Study to Evaluate the Bioavailability of Tazarotene Foam, 0.1%, and Tazorac Gel, 0.1%, in Subjects With Acne Vulgaris
NCT01019603
A Study to Evaluate the Safety and Efficacy of Tazarotene Foam, 0.1%, in Subjects With Common Facial Acne
NCT01017120
A Study to Evaluate the Safety and Efficacy of Tazarotene Foam, 0.1%, in Subjects With Common Facial Acne - W0260-301
NCT01017146
A Study of the Effects of Increasing Doses of a Drug for the Treatment of Nail Fungus
NCT01014962
Compare the Tolerance of Clindamycin 1% /Benzoyl Peroxide (BPO) 5% Gel to Clindamycin 1.2%/ BPO 2.5% Topical Medications
NCT01015638
Study to Determine and Compare the Tolerance and Irritation Potential of Topical Acne Medications
NCT00964366
A Study to Evaluate Tolerability of Two Topical Drug Products in the Treatment of Facial Acne
NCT00964223
Two-week Study to Compare the Tolerance and Irritation Potential of Two Combination Topical Gel Acne Medications
NCT00926367
A Clinical Study to Evaluate the Tolerability of a Topical Antibiotic and Retinoid Used in a Combined Regimen With a BPO Wash
NCT00891982
Retapamulin Versus Linezolid in the Treatment of SITL and Impetigo Due to MRSA
NCT00852540
A Study to Evaluate the Efficacy and Tolerability of Topical Therapies for the Condition of Plaque-Type Psoriasis
NCT00852761
Efficacy and Safety of a Retinoid in the Treatment of Severe Chronic Hand Eczema
NCT00817063
Trial of Clindamycin / Benzoyl Peroxide Gel in Subjects With Acne
NCT00776919
Study to Evaluate Safety, Efficacy and Tolerability of Clobetasol Propionate for Chronic Hand Dermatitis
NCT00828464
Efficacy and Safety Study of 4 Dose Regimens of Oral Albaconazole in Subjects With Distal Subungual Onychomycosis
NCT00730405
Safety and Efficacy Study of Clindamycin/Benzoyl Peroxide/Tazarotene Cream in Subjects With Acne
NCT00713609
Study to Assess Blood Levels of Itraconazole During a Two-Week Period
NCT00695071
A Clinical Study to Evaluate the Safety and Effectiveness of an Investigational Product Called CT Gel
NCT00689117
Study to Compare U0267 Against Vehicle in Subjects With Plaque-type Psoriasis Two of Two Phase 3 Studies
NCT00689481
Study to Compare U0267 Against Vehicle in Subjects With Plaque-type Psoriasis One of Two Phase 3 Studies
NCT00688519
Evaluation of the Efficacy and Tolerability of Clobetasol Propionate Foam Compared to Vehicle Foam
NCT00842153
Comparative Efficacy and Safety of Benzoyl Peroxide Used in Combination With Clindamycin vs. Benzoyl Peroxide Used in Combination With Clindamycin and Doxycycline in the Treatment of Moderate Acne
NCT00837213
Comparative Antimicrobial Efficacy of Two Topical Acne Therapies for the Treatment of Facial Acne
NCT00841776
A Study to Evaluate Efficacy and Safety of Three W0027 Regimens in the Treatment of Moccasin Type Tinea Pedis (MTTP)
NCT00509275
Prospective Two-Year Study to Assess Miconazole Nitrate Resistance in Neonates and Infants
NCT00702507
Itraconazole Tablets Vs. Itraconazole Capsules vs. Placebo in Onychomycosis of the Toenail.
NCT00356915
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 11 |
| Phase 2 | 3 |
| Phase 3 | 11 |
| Phase 4 | 11 |
Therapeutic Areas
How the Stiefel, a GSK Company archive is shaped
37 indexed studies, none listed as recruiting (0% open); 37 completed (100%).
Phase mix: 22 late (III/IV) vs 14 early (I/II) (later-stage heavy).
Top condition: Acne Vulgaris (6 trials), 4 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Stiefel, a GSK Company: archived-pipeline peers nationwide
Peers matched on 37 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Stiefel, a GSK Company sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 37 archived trials
- Appalachian State University · 37 trials · 3% recruiting
- Bracco Diagnostics · 37 trials · 3% recruiting
- Carnegie Mellon University · 37 trials · 11% recruiting
- Cutera · 37 trials · 0% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this Stiefel, a GSK Company page
37 registered trials is a research-attention snapshot, not an endorsement of Stiefel, a GSK Company or any single study.
- None of Stiefel, a GSK Company's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Acne Vulgaris is the condition Stiefel, a GSK Company studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Acne Vulgaris trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Stiefel, a GSK Company pipeline card: 37 registered trials from official public datasets.Report a data error.